Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphomaAndrea Rinaldi, Francesco Bertoni, Ivo Kwee et al.|British Journal of Haematology|2005Cited by 193
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcomeAndrea Rinaldi, Francesco Bertoni, Andrés J.M. Ferreri et al.|Blood|2010Cited by 189
<i>KMT2D</i> mutations and <i>TP53</i> disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL studySimone Ferrero, Gianluca Gaïdano, Davide Rossi et al.|Haematologica|2019Cited by 137
Concomitant<i>MYC</i>and microRNA cluster miR-17-92 (<i>C13orf25</i>) amplification in human mantle cell lymphomaAndrea Rinaldi, Francesco Bertoni, Giulia Poretti et al.|Leukemia & lymphoma/Leukemia and lymphoma|2007Cited by 97
Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphomaPaola Bonetti, Francesco Bertoni, Monica Testoni et al.|Blood|2013Cited by 70